InVivo Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVIV and other ETFs, options, and stocks.

About NVIV

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.

CEO

Richard Toselli

CEORichard Toselli

Employees

Employees7

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2005

Founded2005

Employees

Employees7

NVIV Key Statistics

Market cap

4.40M

Market cap4.40M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

72.18K

Average volume72.18K

High today

—

High today—

Low today

—

Low today—

Open price

$2.34

Open price$2.34

Volume

0.00

Volume0.00

52 Week high

$13.77

52 Week high$13.77

52 Week low

$1.61

52 Week low$1.61

NVIV Earnings

-$2.25

-$1.50

-$0.75

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 6, After Hours

ActualExpected Mar 6, After Hours